The price of Seagen Inc. (NASDAQ: SGEN) closed at $200.48 in the last session, up 0.27% from day before closing price of $199.94. In other words, the price has increased by $+0.54 from its previous closing price. On the day, 1803849 shares were traded. SGEN stock price reached its highest trading level at $200.78 during the session, while it also had its lowest trading level at $198.59.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
We take a closer look at SGEN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.90 and its Current Ratio is at 3.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Raymond James on February 16, 2023, Upgraded its rating to Strong Buy and sets its target price to $175 from $155 previously.
On February 16, 2023, Evercore ISI Upgraded its rating to Outperform which previously was In-line and also upped its target price recommendation from $140 to $175.
SVB Securities Downgraded its Outperform to Market Perform on February 06, 2023, whereas the target price for the stock was revised from $162 to $141.
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 14 when WELCH DANIEL G sold 544 shares for $200.00 per share. The transaction valued at 108,800 led to the insider holds 12,977 shares of the business.
WELCH DANIEL G sold 288 shares of SGEN for $57,600 on Mar 14. The Director now owns 24,306 shares after completing the transaction at $200.00 per share. On Mar 13, another insider, WELCH DANIEL G, who serves as the Director of the company, sold 17,374 shares for $200.36 each. As a result, the insider received 3,481,015 and left with 7,219 shares of the company.
For the stock, the TTM Price-to-Sale (P/S) ratio is 19.20 while its Price-to-Book (P/B) ratio in mrq is 13.30.
Stock Price History:
Over the past 52 weeks, SGEN has reached a high of $202.86, while it has fallen to a 52-week low of $105.43. The 50-Day Moving Average of the stock is 150.77, while the 200-Day Moving Average is calculated to be 148.22.
According to the various share statistics, SGEN traded on average about 1.32M shares per day over the past 3-months and 2.17M shares per day over the past 10 days. A total of 186.11M shares are outstanding, with a floating share count of 183.63M. Insiders hold about 0.30% of the company’s shares, while institutions hold 89.30% stake in the company. Shares short for SGEN as of Jan 12, 2023 were 3M with a Short Ratio of 3.29M, compared to 2.71M on Dec 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.62% and a Short% of Float of 2.18%.
The company has 19 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$1.04 for the current quarter, with a high estimate of -$0.73 and a low estimate of -$1.35, while EPS last year was -$0.95. The consensus estimate for the next quarter is -$0.85, with high estimates of -$0.55 and low estimates of -$1.17.
Analysts are recommending an EPS of between -$3.26 and -$3.86 for the fiscal current year, implying an average EPS of -$3.55. EPS for the following year is -$2.56, with 21 analysts recommending between $0.51 and -$3.86.
According to 18 analysts, the current quarter’s revenue is expected to be $479.55M. It ranges from a high estimate of $512M to a low estimate of $454M. As of the current estimate, Seagen Inc.’s year-ago sales were $429.85M, an estimated increase of 11.60% from the year-ago figure. For the next quarter, 12 analysts are estimating revenue of $497.49M, an increase of 16.70% over than the figure of $11.60% in the same quarter last year. There is a high estimate of $536.9M for the next quarter, whereas the lowest estimate is $461.3M.
A total of 22 analysts have provided revenue estimates for SGEN’s current fiscal year. The highest revenue estimate was $1.95B, while the lowest revenue estimate was $1.89B, resulting in an average revenue estimate of $1.91B. In the same quarter a year ago, actual revenue was $1.57B, up 21.40% from the average estimate. Based on 22 analysts’ estimates, the company’s revenue will be $2.3B in the next fiscal year. The high estimate is $2.62B and the low estimate is $2.08B. The average revenue growth estimate for next year is up 20.50% from the average revenue estimate for this year.